[1] Marino M H. Expression systems for heterologous protein production[J]. Biopharm,1989,2:18
[2] Horn M E, Woodard S L, Howard J A. Plant molecular farming:systems and products[J]. Plant Cell Reports, 2004, 22(10):711-720.
[3] 王瑞刚,王水平.外源蛋白表达系统及利用植物表达外源蛋白的特点与优势[J].生物学通报,2003,38(1):11-12.
[4] 段永波,赵丰兰,倪大虎,等.水稻胚乳表达药用重组蛋白研究进展[J].中国新药杂志,2014(7):787-792.
[5] 杜小春,何正权,陈磊,等.植物生物反应器表达药用蛋白研究新进展[J].中国生物工程杂志,2008,28(9):135-143.
[6] Villiers E M de. Cross-roads in the classification of papillomaviruses[J]. Virology, 2013, 445(1/2):2-10.
[7] Kirnbauer R, Taub J, Greenstone H, et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles[J]. Journal of Virology, 1993, 67(12):6929-6936.
[8] Buck C B, Day P M, Trus B L. The papillomavirus major capsid protein L1[J]. Virology, 2013, 445(1/2):169-174.
[9] Hanumantha RAO N, Bajibabu P, Rajendra L, et al. Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichiapastoris; purification and characterization of the virus-like particles[J]. Vaccine, 2011, 29(43):7326-7334.
[10] Mckee S J, Bergot A S, Leggatt G R. Recent progress in vaccination against human papillomavirus-mediated cervical cancer[J]. Reviews in Medical Virology, 2015, 25(1):54-71.
[11] Shaw A R. Human papillomavirus vaccines six years after approval[J]. Annual Review of Medicine, 2013, 64(1):91-100.
[12] Mason H S, Ball J M, Shi J J, et al. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice[J]. Proceedings of the National Academy of Sciences of the United States of America, 1996, 93(11):5335-5340.
[13] Mcgarvey P B, Hammond J, Dienelt M M, et al. Expression of the rabies virus glycoprotein in transgenic tomatoes[J]. Bio/Technology, 1995, 13(13):1484-1487.
[14] Wigdorovitz A, Carrillo C, Dus Santos M J, et al. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1[J]. Virology, 1999, 255(2):347-353.
[15] Kumar S, Biswas M, Jose T. HPV vaccine:Current status and future directions[J]. Medical Journal Armed Forces India, 2015, 71(2):171-177.
[16] Wang J W, Roden R B. Virus-like particles for the prevention of human papillomavirus-associated malignancies[J]. Expert Review of Vaccines, 2013, 12(2):129-141.
[17] Warzecha H, Mason H S, Lane C, et al. Oral immunogenicity of human papillomavirus-like particles expressed in potato[J]. Journal of Virology, 2003, 77(16):8702-8711.
[18] Kohl T O, Hitzeroth I I, Christensen N D, et al. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum[J]. BMC Biotechnology, 2007, 7(3):56.
[19] Lamprecht R L, Kennedy P, Huddy S M, et al. Production of human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells[J]. Scientific Reports, 2016, 6:20431.
[20] He Yang, NING Tingting, XIE Tingting, et al. Large-scale production of functional human serum albumin from transgenic rice seeds[J]. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(47):19078-19083.
[21] AN Na, OU Jiquan, JIANG Daiming, et al. Expression of a functional recombinant human basic fibroblast growth factor from transgenic rice seeds[J]. International Journal of Molecular Sciences, 2013, 14(2):3556-3567. |